Effect of corticosteroids on the outcome of patients with advanced non –small cell lung cancer treated with immune-checkpoint inhibitors
We analysed patients with advanced non –small cell lung cancer (NSCLC) who were treated with immune-checkpoint inhibitors (ICIs) to address the effect of the timeline and reason for corticosteroid administration on survival outcomes.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Marcus Skribek, Konstantinos Rounis, Soren Afshar, Oscar Grundberg, Signe Friesland, Georgios Tsakonas, Simon Ekman, Luigi De Petris Tags: Original Research Source Type: research
More News: Cancer | Cancer & Oncology | Corticosteroid Therapy | Lung Cancer | Non-Small Cell Lung Cancer